Alvotech Announces That the U.S. FDA and EMA Have Accepted Regulatory Submissions for AVT02, a Proposed Biosimilar to HUMIRA (adalimumab)

REYKJAVIK, Iceland--(BUSINESS WIRE)--Nov 19, 2020-- |!| Keokuk